{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:03Z","timestamp":1787889963989,"version":"build-2784847793"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231031","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T17:33:42Z","timestamp":1586367222000},"page":"e0231031","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-4925","authenticated-orcid":true,"given":"Augustine O.","family":"Udeze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Olaleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-0147","authenticated-orcid":true,"given":"Georgina N.","family":"Odaibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"pone.0231031.ref001","doi-asserted-by":"crossref","first-page":"W13","DOI":"10.1097\/01.aids.0000247564.73009.bc","article-title":"Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004","volume":"20","author":"J Hemelaar","year":"2006","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"pone.0231031.ref002","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/jmv.20599","article-title":"Global epidemiology of HIV","volume":"78","author":"FE McCutchan","year":"2006","journal-title":"J Med Virol"},{"key":"pone.0231031.ref003","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/108729104323076007","article-title":"Preventing and managing antiretroviral drug resistance","volume":"18","author":"DR Kuritzkes","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"pone.0231031.ref004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350000500112","article-title":"The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan","volume":"5","author":"V DeGruttola","year":"2000","journal-title":"Antivir Ther"},{"key":"pone.0231031.ref005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJMra1004180","article-title":"Mechanisms of disease development of antiretroviral drug resistance","volume":"365","author":"MA Wainberg","year":"2011a","journal-title":"N Engl J Med"},{"key":"pone.0231031.ref006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAI.0b013e318227fc34","article-title":"Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa","volume":"58","author":"KC Sigaloff","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0231031.ref007","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/jama.300.5.530","article-title":"Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy","volume":"300","author":"A Boulle","year":"2008","journal-title":"J Am Med Assoc"},{"key":"pone.0231031.ref008","doi-asserted-by":"crossref","first-page":"e13414","DOI":"10.1371\/journal.pone.0013414","article-title":"Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, C\u00f4te d\u2019Ivoire","volume":"5","author":"Affiliations INSERM U897, Bordeaux, France, Programme PACCI","year":"2010","journal-title":"PloS One"},{"issue":"7","key":"pone.0231031.ref009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMra1004180","article-title":"Development of antiretroviral drug resistance","volume":"365","author":"MA Wainberg","year":"2011b","journal-title":"The N Engl J Med"},{"key":"pone.0231031.ref010","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/00002030-200406003-00012","article-title":"HIV-1 Subtype Distribution and the Problem of Drug Resistance","volume":"18","author":"MA Wainberg","year":"2004","journal-title":"AIDS"},{"key":"pone.0231031.ref011","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1386-6532(03)00115-X","article-title":"Drug Resistance in Non-Subtype B HIV-1","volume":"29","author":"R Kantor","year":"2004","journal-title":"J Clin Virol"},{"key":"pone.0231031.ref012","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/aid.2006.22.770","article-title":"Subtype-Specific Patterns in HIV Type 1 Reverse Transcriptase and Protease in Oyo State, Nigeria: Implications for Drug Resistance and Host Response","volume":"22","author":"AI Ojesina","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0231031.ref013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/aid.2006.22.22","article-title":"Genotypic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 in Antiretroviral Drug-Naive Nigerian Patients","volume":"22","author":"SM Agwale","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"pone.0231031.ref014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/aid.2010.0050","article-title":"Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy","volume":"27","author":"B Chaplin","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"S4","key":"pone.0231031.ref015","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/cid\/cir1064","article-title":"Virological Response and HIV Drug Resistance 12 Months after Antiretroviral Therapy Initiation at 2 Clinics in Nigeria","volume":"54","author":"R Ugbena","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"17","key":"pone.0231031.ref016","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.5897\/AJB2013.11954","article-title":"Human immunodeficiency virus type-1 (HIV-1) genetic diversity and prevalence of antiretroviral drug resistance mutations in treatment-na\u00efve adults in Jos, North Central Nigeria","volume":"12","author":"JA Anejo-Okopi","year":"2013","journal-title":"African Journal of Biotechnology"},{"key":"pone.0231031.ref017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4236\/wja.2013.34042","article-title":"Pattern of HIV-1 drug resistance among adults on ART in Nigeria","volume":"3","author":"GN Odaibo","year":"2013","journal-title":"World J AIDS"},{"issue":"2","key":"pone.0231031.ref018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/aid.2013.0074","article-title":"Transmitted HIV Drug Resistance in Antiretroviral-Na\u00efve Pregnant Women in North Central Nigeria","volume":"30","author":"GE Imade","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0231031.ref019","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4236\/wja.2014.42024","article-title":"Antiretroviral-Drug Resistant Mutations and Genetic Diversity in HIV-1 Infected Individuals in Nigeria","volume":"4","author":"OR Negedu-Momoh","year":"2014","journal-title":"World J AIDS"},{"key":"pone.0231031.ref020","doi-asserted-by":"crossref","first-page":"21140","DOI":"10.7448\/IAS.19.1.21140","article-title":"High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children","volume":"19","author":"RS Boerma","year":"2016","journal-title":"JIAS"},{"key":"pone.0231031.ref021","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12981-017-0184-5","article-title":"Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program","volume":"14","author":"ST Meloni","year":"2017","journal-title":"AIDS Res Ther"},{"key":"pone.0231031.ref022","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2010 revisions). Geneva, Switzerland, World Health Organization. Available at: http:\/\/www.who.int\/hiv\/pub\/arv\/adult2010\/en\/index.html"},{"key":"pone.0231031.ref023","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. (2013) Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/en\/"},{"key":"pone.0231031.ref024","unstructured":"World Health Organization, Geneva, Consolidated guidelines on the use of antiretroviral drugs for treating HIV infection. Recommendations for public health approach. 2nd ed. 422 (2016) p. Available at http:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/"},{"key":"pone.0231031.ref025","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"K Tamura","year":"2011","journal-title":"Mol Biol Evol"},{"issue":"4","key":"pone.0231031.ref026","first-page":"132","article-title":"Update of the drug resistance mutations in HIV-1: International AIDS Society-USA","volume":"23","author":"AM Wensing","year":"2015","journal-title":"Top Antivir Med"},{"issue":"4","key":"pone.0231031.ref027","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2516.1998.440610.x","article-title":"Resistance to HIV protease inhibitors","volume":"4","author":"CA Lee","year":"1998","journal-title":"Haemophilia"},{"key":"pone.0231031.ref028","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.79.6.3329-3338.2005","article-title":"Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlates","volume":"79","author":"H Mo","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"pone.0231031.ref029","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3923\/ijv.2011.13.23","article-title":"Drug resistance mutations to protease and reverse transcriptase inhibitors in treatment na\u00efve HIV-1 clade C infected individuals from Mumbai, India","volume":"7","author":"PD Potdar","year":"2011","journal-title":"International Journal of Virology"},{"issue":"9","key":"pone.0231031.ref030","doi-asserted-by":"crossref","first-page":"e73582","DOI":"10.1371\/journal.pone.0073582","article-title":"Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria","volume":"8","author":"Affiliation Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America \u2a2f Olaitan O, Scarsi KK, Affiliation AIDS Prevention Initiative in Nigeria, Abuja, Nigeria","year":"2013","journal-title":"Plos One"},{"issue":"17","key":"pone.0231031.ref031","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/00002030-199912030-00006","article-title":"Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy","volume":"13","author":"M Nijhuis","year":"1999","journal-title":"AIDS"},{"issue":"2","key":"pone.0231031.ref032","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.qai.0000219787.65915.56","article-title":"An increase in viral replicative capacity drives the evolution of protease inhibitor-resistant human immunodeficiency virus type 1 in the absence of drugs","volume":"42","author":"NM van Maarseveen","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0231031.ref033","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2005.11.006","article-title":"Polymorphism and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains","volume":"11","author":"S Paraschiv","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"6","key":"pone.0231031.ref034","doi-asserted-by":"crossref","first-page":"e37983","DOI":"10.1371\/journal.pone.0037983","article-title":"Minor Protease Inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients","volume":"7","author":"UA Scherrer","year":"2012","journal-title":"PLoS One"},{"key":"pone.0231031.ref035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1011812810397","article-title":"Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type I found in Brazilian patients failing HAART","volume":"23","author":"E Caride","year":"2001","journal-title":"Virus Genes"},{"key":"pone.0231031.ref036","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00002030-200108170-00001","article-title":"Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B","volume":"15","author":"Z Grossman","year":"2001","journal-title":"AIDS"},{"key":"pone.0231031.ref037","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00002030-200205240-00010","article-title":"High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid","volume":"16","author":"A Holgu\u00edn","year":"2002","journal-title":"AIDS"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T22:25:27Z","timestamp":1666304727000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231031"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231031","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]}}}